Group One Trading, L.P. Eton Pharmaceuticals, Inc. Transaction History
Group One Trading, L.P.
- $2.4 Billion
- Q3 2024
A detailed history of Group One Trading, L.P. transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 722 shares of ETON stock, worth $12,035. This represents 0.0% of its overall portfolio holdings.
Number of Shares
722Holding current value
$12,035% of portfolio
0.0%Shares
6 transactions
Others Institutions Holding ETON
# of Institutions
52Shares Held
9.43MCall Options Held
261KPut Options Held
500-
Opaleye Management Inc. Boston, MA2.78MShares$46.3 Million3.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.03MShares$17.1 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT999KShares$16.6 Million0.36% of portfolio
-
Acuitas Investments, LLC580KShares$9.67 Million1.66% of portfolio
-
Westside Investment Management, Inc.575KShares$9.59 Million1.61% of portfolio
About Eton Pharmaceuticals, Inc.
- Ticker ETON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,297,000
- Market Cap $422M
- Description
- Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...